NCT06536582View on ClinicalTrials.gov

Nutrition Impact on PRGF Treatment for Tendinopathy

RecruitingOBSERVATIONAL
Enrollment

52

Participants

Timeline

Start Date

February 15, 2024

Primary Completion Date

August 15, 2026

Study Completion Date

February 15, 2027

Conditions
Shoulder TendinopathyMetabolic Alterations
Interventions
BIOLOGICAL

Platelet rich growth factor injection (autologous product)

All patients will undergo two PRGF injections, one at recruitment and one 14 days after the first injection. The injection site will be the shoulder with tendinopathy.

Trial Locations (1)

20173

RECRUITING

I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio, Milan

All Listed Sponsors
lead

I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio

OTHER